Plasma concentrations of endothelial vasoactive substances in clinically healthy subjects. Associations with urinary albumin excretion and ambulatory blood pressure

REFERENCES

• Deckert T, Yokoyama H, Mathiesen E, Rolm B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. Br Med J 1996; 312: 871–4.
   Google Scholar
• Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 1413–8.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Forrest RD, Jackson CA. Micro-albuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 1988; 2: 530–3.
   Google Scholar
• Borch-JohnsenK,Feldt-RasmussenB,Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion—an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992–7.
   Google Scholar
• Clausen P, Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects. Hypertension 1998; 32: 71–7.
   Google Scholar
• Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis 1995; 112: 245— 56.
   Google Scholar
• Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage—the Steno hypothesis. Diabetologia 1989; 32: 219–26.
   PubMed Web of Science ®Google Scholar
• Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a gen-eralized transvascular albumin leakiness in clini-cally healthy subjects. Clin Sci 1995; 88: 629— 33.
   Google Scholar
• Vane JR., Angaard EE, Botting RM. Mechanisms of disease: regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27 — 36.
   Google Scholar
• Nava E, Liischer TF. Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin. J Hypertens (1995); 13 Suppl ; 2: S39–48.
   Google Scholar
• Boger RH, Bode-B6ger SM, Frölich JC. The L-arginine-nitric oxide pathway: role in atherosclero-sis and therapeutic implications. Atherosclerosis 1996; 127: 1–11.
   PubMed Web of Science ®Google Scholar
• Parrinello G, Scaglione R, Pinto A, Corrao S, Cecala M, Di Silvestre G, Amato P, Licata A, Licata G. Central obesity and hypertension. The role of plasma endothelin. Am J Hypertens 1996; 9: 1186–91.
   PubMed Web of Science ®Google Scholar
• Lerman Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced athero-sclerosis. N Engl J Med 1991; 325: 997–1001.
   Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–9.
   PubMed Web of Science ®Google Scholar
• The Copenhagen City Heart Study Group. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976–78) and a five-year follow-up (1981–83). Scand J Soc Med 1989; 170 Suppl 41: S1–160
   Google Scholar
• Clausen P, Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Prevalence of positive dipstick analysis (leucocyte esterase, nitrite, haemoglobin, or glucose) in a population of 3645 adult subjects. Consequence for measurement of urinary albumin excretion rate. Scand J Urol Nephrol 1998; 32: 399–404.
   Google Scholar
• Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin excretion in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539–44.
   Google Scholar
• Jensen JS. Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle aged individuals. Clin Chim Acta 1995; 243: 95–9.
   PubMed Web of Science ®Google Scholar
• Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837–42.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Nakanishi T, Nishimura M, Tanaka H, Yoshimura M. Measurements of serum levels of nitrate ions in men and women: implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J Cardio-vasc Pharmacology (1992); 20 Suppl ; 12: S214 — 6.
   Google Scholar
• Goonasekera CDA, Shah V, Rees DD, Dillon MJ. Nitric oxide activity in childhood hypertension. Arch Dis Child 1997; 77: 11–6.
   PubMed Web of Science ®Google Scholar
• Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi K, Azuma C, Saji F. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 1996; 41: 189–93.
   PubMed Web of Science ®Google Scholar
• Nava E, Leone AM, Wiklund NP, Moncada S Detection of release of nitric oxide by vasoactive substances in the anaesthesized rat. In: Feelisch M, Busse R, Moncada S, editors. The biology of nitric oxide. London: Portland Press; (1994). p. 179–81
   Google Scholar
• Nava E, Wiklund NP, Salazar FJ. Changes in nitric oxide release in vivo in response to vasoactive substances. Br J Pharmacol 1996; 119: 1211–6.
   Google Scholar
• Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4: 303–8.
   PubMed Web of Science ®Google Scholar
• Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493–6.
   PubMed Web of Science ®Google Scholar
• Rhodes PM, Leone AM, Francis PL, Struthers AD, Moncada S. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Com 1995; 209: 590–6.
   Google Scholar